NELSEN ROBERT

SEC Form 4 insider trading activity

NELSEN ROBERT has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 19, 2026.

On the most recent filing, NELSEN ROBERT is listed as Director, 10% Owner at CITY THERAPEUTICS, INC. Inside the rolling window, NELSEN ROBERT reported 1 open-market purchase totaling $3.1M in CTY and no open-market sales.

Companies traded

Other insiders at CTY

Insider Buying

$3.1M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
CTY
NELSEN ROBERT
Purchase$3.1MOct 19SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has NELSEN ROBERT made?

NELSEN ROBERT has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.

Which companies does NELSEN ROBERT trade?

NELSEN ROBERT has filed SEC Form 4 disclosures for 1 company, including CTY.

When was NELSEN ROBERT's most recent SEC Form 4 filing?

NELSEN ROBERT's most recent SEC Form 4 filing on Tracefour is dated Oct 19, 2026.

What is NELSEN ROBERT's total buy and sell value in the current window?

Inside the rolling retention window, NELSEN ROBERT bought $3.1M and sold $0 based on SEC Form 4 filings.

What was NELSEN ROBERT's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 170,000 CTY shares on 2026-10-19, worth $3.1M, per SEC Form 4 filings.